Esperion Therapeutics Stock Investor Sentiment
| ESPR Stock | USD 2.09 0.18 9.42% |
Slightly above 56% of all Esperion Therapeutics' retail investors are looking to take a long position. The analysis of the overall investor sentiment regarding Esperion Therapeutics suggests that some traders are interested. Esperion Therapeutics' investor sentiment overview provides quick insight into current market opportunities from investing in Esperion Therapeutics. The current market sentiment, together with Esperion Therapeutics' historical and current headlines, can help investors time the market. In addition, many technical investors use Esperion Therapeutics stock news signals to limit their universe of possible portfolio assets and to time the market correctly.
Esperion Therapeutics stock news, alerts, and headlines are usually related to its technical, predictive, social, and fundamental indicators. It can reflect on the current distribution of Esperion daily returns and investor perception about the current price of Esperion Therapeutics as well as its diversification or hedging effects on your existing portfolios.
Esperion |
Esperion Therapeutics Sentiment by Major News Outlets
Investor sentiment, mood or attitude towards Esperion Therapeutics can have a significant impact on its stock price or the market as a whole. This sentiment can be positive or negative, and various factors, such as economic indicators, news events, or market trends, can influence it. When investor sentiment is positive, investors are more likely to buy stocks, increasing demand and increasing the stock price. Positive investor sentiment can be driven by good news about the company or the broader market, such as solid earnings reports or positive economic data.
Note that negative investor sentiment can cause investors to sell stocks, leading to a decrease in demand and a drop in the stock price. Negative sentiment can be driven by factors such as poor earnings reports, negative news about the company or industry, or broader economic concerns. It's important to note that investor sentiment is just one of many factors that can affect stock prices. Other factors, such as company performance, industry trends, and global economic conditions, can also play a significant role in determining the value of a stock.
Far too much social signal, news, headlines, and media speculation about Esperion Therapeutics that are available to investors today. That information is available publicly through Esperion media outlets and privately through word of mouth or via Esperion internal channels. However, regardless of the origin, that massive amount of Esperion data is challenging to quantify into actionable patterns, especially for investors that are not very sophisticated with ever-evolving tools and techniques used in the investment management field.
A primary focus of Esperion Therapeutics news analysis is to determine if its current price reflects all relevant headlines and social signals impacting the current market conditions. A news analyst typically looks at the history of Esperion Therapeutics relative headlines and hype rather than examining external drivers such as technical or fundamental data. It is believed that price action tends to repeat itself due to investors' collective, patterned thinking related to Esperion Therapeutics' headlines and news coverage data. This data is often completely overlooked or insufficiently analyzed for actionable insights to drive Esperion Therapeutics alpha.
Esperion Therapeutics Performance against NYSE Composite
Price Growth (%) |
| Timeline |
1 | Can Low Occupancy Rate Affect Select Medical Q4 Earnings | 02/20/2024 |
2 | Esperion Therapeutics Earns Buy Rating from Needham Company LLC | 03/01/2024 |
3 | Acquisition by Sheldon Koenig of 642000 shares of Esperion Therapeutics at 2.05 subject to Rule 16b-3 | 03/14/2024 |
4 | CHMP Issues Positive Opinions For Both Bempedoic Acid And The Bempedoic Acid Ezetimibe Fixed-Dose Combination Tablet As Treatments For Hypercholesterolemia And ... | 03/22/2024 |
5 | Why Is Heart Disease-Focused Esperion Therapeutics Stock Trading Higher On Monday | 03/25/2024 |
6 | One Biosciences WelcomesDr. Scott Braunstein and Dr. Vincent Millerto its Board of Directors | 03/27/2024 |
7 | Esperion Therapeutics, Inc. Shares Sold by Pinnacle Associates Ltd. - Defense World | 04/03/2024 |
8 | Form DEF 14A Esperion Therapeutics, For Apr 11 - StreetInsider.com | 04/11/2024 |
Check out Esperion Therapeutics Hype Analysis, Esperion Therapeutics Correlation and Esperion Therapeutics Performance. To learn how to invest in Esperion Stock, please use our How to Invest in Esperion Therapeutics guide.You can also try the Financial Widgets module to easily integrated Macroaxis content with over 30 different plug-and-play financial widgets.
Complementary Tools for Esperion Stock analysis
When running Esperion Therapeutics' price analysis, check to measure Esperion Therapeutics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Esperion Therapeutics is operating at the current time. Most of Esperion Therapeutics' value examination focuses on studying past and present price action to predict the probability of Esperion Therapeutics' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Esperion Therapeutics' price. Additionally, you may evaluate how the addition of Esperion Therapeutics to your portfolios can decrease your overall portfolio volatility.
| Portfolio Anywhere Track or share privately all of your investments from the convenience of any device | |
| Risk-Return Analysis View associations between returns expected from investment and the risk you assume | |
| Portfolio Volatility Check portfolio volatility and analyze historical return density to properly model market risk | |
| Portfolio Diagnostics Use generated alerts and portfolio events aggregator to diagnose current holdings | |
| Commodity Channel Use Commodity Channel Index to analyze current equity momentum | |
| Companies Directory Evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals | |
| Economic Indicators Top statistical indicators that provide insights into how an economy is performing | |
| Sectors List of equity sectors categorizing publicly traded companies based on their primary business activities | |
| CEOs Directory Screen CEOs from public companies around the world | |
| Money Managers Screen money managers from public funds and ETFs managed around the world | |
| Idea Optimizer Use advanced portfolio builder with pre-computed micro ideas to build optimal portfolio | |
| ETFs Find actively traded Exchange Traded Funds (ETF) from around the world | |
| Odds Of Bankruptcy Get analysis of equity chance of financial distress in the next 2 years |
Is Esperion Therapeutics' industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Esperion Therapeutics. If investors know Esperion will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Esperion Therapeutics listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (2.03) | Revenue Per Share 1.128 | Quarterly Revenue Growth 0.714 | Return On Assets (0.43) | Return On Equity (2.61) |
The market value of Esperion Therapeutics is measured differently than its book value, which is the value of Esperion that is recorded on the company's balance sheet. Investors also form their own opinion of Esperion Therapeutics' value that differs from its market value or its book value, called intrinsic value, which is Esperion Therapeutics' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Esperion Therapeutics' market value can be influenced by many factors that don't directly affect Esperion Therapeutics' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Esperion Therapeutics' value and its price as these two are different measures arrived at by different means. Investors typically determine if Esperion Therapeutics is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Esperion Therapeutics' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.